Refine
Has Fulltext
- yes (15) (remove)
Is part of the Bibliography
- yes (15)
Year of publication
Document Type
- Journal article (8)
- Doctoral Thesis (7)
Keywords
- hypertension (15) (remove)
Institute
- Medizinische Klinik und Poliklinik I (6)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (3)
- Institut für Klinische Epidemiologie und Biometrie (3)
- Institut für Pharmakologie und Toxikologie (3)
- Abteilung für Parodontologie (in der Poliklinik für Zahnerhaltung und Parodontologie) (1)
- Comprehensive Cancer Center Mainfranken (1)
- Institut für Pharmazie und Lebensmittelchemie (1)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (1)
- Medizinische Klinik (bis 2004) (1)
- Physiologisches Institut (1)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 633983 (1)
Acute and chronic cardiac disorders predispose to alterations in cognitive performance, ranging from mild cognitive impairment to overt dementia. Although this association is well-established, the factors inducing and accelerating cognitive decline beyond ageing and the intricate causal pathways and multilateral interdependencies involved remain poorly understood. Dysregulated and persistent inflammatory processes have been implicated as potentially causal mediators of the adverse consequences on brain function in patients with cardiac disease. Recent advances in positron emission tomography disclosed an enhanced level of neuroinflammation of cortical and subcortical brain regions as an important correlate of altered cognition in these patients. In preclinical and clinical investigations, the thereby involved domains and cell types of the brain are gradually better characterized. Microglia, resident myeloid cells of the central nervous system, appear to be of particular importance, as they are extremely sensitive to even subtle pathological alterations affecting their complex interplay with neighboring astrocytes, oligodendrocytes, infiltrating myeloid cells, and lymphocytes. Here, we review the current evidence linking cognitive impairment and chronic neuroinflammation in patients with various selected cardiac disorders including the aspect of chronic neuroinflammation as a potentially druggable target.